β Conference Call Today at 4:30 p.m. ET Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as...
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended March 31, 2025, on...
Omeros Corporation (Nasdaq: OMER) (βOmerosβ or the βCompanyβ) today announced that it has entered into exchange agreements (the βExchange...
Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of...
β The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers...
-- Targeted Complement Activating Therapyβ’ Represents Next-Generation, Broadly Applicable Antimicrobial Therapeutics β Omeros Corporation...
β Conference Call Today at 4:30 p.m. ET β Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as...
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended December 31...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads